CRRSP13 Antibody

Antibody Nomenclature Analysis

• No "CRRSP13" identifier appears in any publication, structural study, or clinical trial report.

• The alphanumeric pattern "CRRSP13" does not align with established naming conventions for antibodies (e.g., "CR" + numeric code or "CR" + alphanumeric for specific epitopes).

Cross-Referencing with Known Antibody Classes

The search results highlight key antibodies and their functions:

CRRSP13 is absent from these tables and all contextual discussions of antibody structures, neutralization mechanisms, or therapeutic applications.

Potential Explanations for the Absence

1. Typographical Error: The name may be misspelled or conflated with similar identifiers (e.g., "CR3022" ).

2. Proprietary/Unpublished: CRRSP13 could be a confidential compound under development, not yet disclosed in public databases.

3. Misattribution: The antibody might be referenced under a different name in non-English literature or preprint servers not included in the search results.

Recommendations for Further Inquiry

To resolve this discrepancy:

• Verify nomenclature with primary research institutions or patent databases.

• Expand search parameters to include non-English journals or preprints (e.g., bioRxiv, medRxiv).

• Contact authors of related studies (e.g., Crucell/Johnson & Johnson for "CR"-series antibodies ).